Cargando…
The role of FDG-PET/CT in gynaecological cancers
There is now a growing body of evidence supporting the use of fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in gynaecological malignancies. Although this molecular imaging technique is becoming increasingly available, PET/CT remains an expensive imaging tool. I...
Autores principales: | Rockall, Andrea G, Cross, Susan, Flanagan, Sean, Moore, Elizabeth, Avril, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335332/ https://www.ncbi.nlm.nih.gov/pubmed/22391444 http://dx.doi.org/10.1102/1470-7330.2012.0007 |
Ejemplares similares
-
The role of (18)F-FDG PET CT in common gynaecological malignancies
por: Narayanan, Priya, et al.
Publicado: (2017) -
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
por: Lakhani, A, et al.
Publicado: (2015) -
Magnetic resonance lymphography in gynaecological malignancies
por: Jahan, Noor, et al.
Publicado: (2010) -
Radiological appearances of gynaecological emergencies
por: Roche, Oran, et al.
Publicado: (2012) -
Impact of (18)F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
por: Vees, Hansjörg, et al.
Publicado: (2012)